[ad_1] <br><div id=""> <p>Investing.com - Icosavax reported on Monday third quarter that beat analysts' forecasts and income that fell in need of expectations.</p> <p>Icosavax introduced earnings per share of $-0.41 on income of $500K. Analysts polled by Investing.com anticipated EPS of $-0.55 on income of $900K. </p> <p>Icosavax shares are down 30% from the start of the yr and are buying and selling at $2.32 , down-from-52-week-high.</p>
<h2>Icosavax follows different main Healthcare sector earnings this month</h2>
<p>Icosavax's report follows an earnings beat by <span>J&J</span> on Tuesday, October 18, 2022, who reported EPS of $2.55 on income of $23.79B, in comparison with forecasts EPS of $2.48 on income of $23.36B.</p> <p><span>Eli Lilly</span> had beat expectations on Tuesday, November 1, 2022 with third quarter EPS of $1.98 on income of $6.94B, in comparison with forecast for EPS of $1.91 on income of $6.91B.</p> <p>Keep up-to-date on the entire upcoming earnings reviews by visiting <a target="_blank" href="https://www.investing.com/earnings-calendar/" rel="noopener">Investing.com's earnings calendar</a></p> </div> <br>[ad_2] <br><a href="https://news.google.com/__i/rss/rd/articles/CBMiUWh0dHBzOi8vaW4uaW52ZXN0aW5nLmNvbS9uZXdzL2ljb3NhdmF4LWVhcm5pbmdzLWJlYXQtcmV2ZW51ZS1taXNzZXMtaW4tcTMtMzQyMTcyMdIBAA?oc=5">Source link </a>